Parametric Portfolio Associates’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $365K | Sell |
20,981
-6,845
| -25% | -$119K | ﹤0.01% | 3217 |
|
|
2021
Q4 | $609K | Buy |
27,826
+1,126
| +4% | +$24.6K | ﹤0.01% | 2988 |
|
|
2021
Q3 | $510K | Sell |
26,700
-4,589
| -15% | -$87.7K | ﹤0.01% | 3101 |
|
|
2021
Q2 | $537K | Sell |
31,289
-380
| -1% | -$6.52K | ﹤0.01% | 3054 |
|
|
2021
Q1 | $708K | Buy |
31,669
+10,723
| +51% | +$240K | ﹤0.01% | 3318 |
|
|
2020
Q4 | $466K | Buy |
20,946
+3,380
| +19% | +$75.2K | ﹤0.01% | 3413 |
|
|
2020
Q3 | $259K | Sell |
17,566
-4,120
| -19% | -$60.7K | ﹤0.01% | 3544 |
|
|
2020
Q2 | $321K | Buy |
21,686
+4,065
| +23% | +$60.2K | ﹤0.01% | 3447 |
|
|
2020
Q1 | $193K | Sell |
17,621
-2,106
| -11% | -$23.1K | ﹤0.01% | 3563 |
|
|
2019
Q4 | $173K | Sell |
19,727
-99
| -0.5% | -$868 | ﹤0.01% | 3774 |
|
|
2019
Q3 | $148K | Buy |
19,826
+1,512
| +8% | +$11.3K | ﹤0.01% | 3772 |
|
|
2019
Q2 | $171K | Buy |
18,314
+5,162
| +39% | +$48.2K | ﹤0.01% | 3767 |
|
|
2019
Q1 | $69K | Buy |
+13,152
| New | +$69K | ﹤0.01% | 3855 |
|
|
2017
Q4 | – | Sell |
-34,310
| Closed | -$401K | – | 3938 |
|
|
2017
Q3 | $401K | Sell |
34,310
-2,255
| -6% | -$26.4K | ﹤0.01% | 3544 |
|
|
2017
Q2 | $511K | Buy |
36,565
+13,911
| +61% | +$194K | ﹤0.01% | 3358 |
|
|
2017
Q1 | $311K | Sell |
22,654
-473
| -2% | -$6.49K | ﹤0.01% | 3410 |
|
|
2016
Q4 | $166K | Sell |
23,127
-464
| -2% | -$3.33K | ﹤0.01% | 3628 |
|
|
2016
Q3 | $358K | Buy |
23,591
+298
| +1% | +$4.52K | ﹤0.01% | 3339 |
|
|
2016
Q2 | $229K | Buy |
+23,293
| New | +$229K | ﹤0.01% | 3554 |
|